enrico bertini, convegno mitocon 2014
TRANSCRIPT
Encefalopatie ed epatopatie nelle patologia mitocondriali
Dr. Enrico Bertini, OBG Hospital, Rome, Italy [email protected]
Clinical, biochemical and neuroimaging Classification
• Leigh syndromes • Encephalopathy and recurrent Strokes • Encephalopathy and ataxia • Developmental malformations • Leukodystrophies • Poliodystrophies • Pan-encephalopathies
Mitochondrial Encephalopathies
Leigh syndromes Disease Abbreviation MIM # Gene Hints from clinical
findings or routine studies
Diagnostic tests
Leigh syndrome
LS MILS MtDNA LS
256000 ND1-ND6 CO3 ATP6 tRNA Leu tRNA Lys tRNA Trp tRNA Val
MRI: pattern characteristic, (MRS): lactate elevated Complex I defect Complex III defect Complex IV defect Complex V defect
MolGenet
Leigh syndrome
nDNA LS 20111 603647 600857 602694 609653 602137 238331 612392 185620 603646 603846 161015 602141 613622 601825
SUCLA2 SUCLG1 BCS1L NDUFS4 NDUFAF2 NDUFA2 NDUFS3 NDUFV1 NDUFA9 NDUFS8 NDUFS7 NDUFAF5 NDUFAF6 NDUFA10
SURF-1 PDH DLD SDHA C8orf38 COX15 COX10 FOXRED1 LRPPRC TACO1 C12orf65 MTFMT NDUFA12
MRI: pattern characteristic, (MRS): lactate elevated Complex I defect Complex II defect Complex III defect Complex IV defect Complex V defect
MG Biochemistry
2002 2008 2009
2008 2009
9 year old female, ND5 13513G>A
MTT: mamillothalamic tracts ML: medial lemniscus STT: spinothalamic tracts FG: fasciculus gracilis MLF: medial longitudinal fasciculus
NDUFA12L female girl, consanguinity, complex 1 defect
Barghuti et al; Molecular Genetics and Metabolism 94 (2008) 78–82
NDUFV1, boy, consangunity, complex I defect
Vilain et al., Clin Genet, 2011
LRPPRC; Leigh syndrome with cytochrome c oxidase deficiency Debray et al., J Med Genet 2011;48:183-189
Encephalopathy and recurrent Strokes Disease Abeviation MIM # Gene Hints from clinical
findings or routine studies
Diagnostic tests
MELAS MT TK 611105 tRNA Le 3243u
MRI: pattern characteristic, (MRS): lactate elevated
MG
MELAS/MERFF MTTL 590060 tRNA Lys T8356C same MG
MELAS MTTF 590070 tRNA Phe G583A
same MG
MELAS/MERFF MTTH, 590040 tRNA His G12147A same MG
MELAS MTTQ 590030 tRNA Glu 1-BP INS, 4366A
same MG
MELAS/ Pakinsonism
MTCYB 516020 Cytb 4-bp deletion same MG
MELAS MTND3-MTND5 516002 516003 516006
ND3-ND5 same MG
Encephalopathy MTDPS4A 271245 POLG1 MRI: pattern characteristic, (MRS): lactate elevated
MG
8 year old Male, one brother and 2 affected cousins MELAS 3243 tRNA LEU (50% in blood)
2004
2003
Encephalopathy and ataxia Disease
Abbreviation MIM # Gene Hints from clinical findings or routine studies
Diagnostic tests
Mitochondrial encephalopathy ragged red fibres
MERFF 545000 A8344G mtDNA tRNA Lys
MRI: pattern characteristic, (MRS): lactate elevated
MG
Sensory ataxia with neuropathy, dysarthria and ophthalmoparesis
SANDO
607459 POLG1 MRI: cerebellar atrophy, neuropathy
MG
Mitochondrial recessive ataxia syndrome
MIRAS 607459 POLG1 MRI: cerebellar atrophy
MG
Ubiquinone deficiency with cerebellar ataxia and seizures
CABC1/COQ8
606980 ADK3 MRI: cerebellar atrophy Muscle:biopsy:/fibroblasts reduction CoQ10
MG
Infantile-onset spinocerebellar ataxia
IOSCA/MTDPS7 606075 Twinkle C10orf2
Ataxia, neuropathy MG
Developmental malformations
Disease Abbreviation MIM # Gene Hints from clinical findings or routine studies
Diagnostic tests
PDH deficiency PDH defect 300502 Ε1α MRI: CC disgenesis; cerebral atrophy (MRS): lactate elevated
MG
Cerebellar hypoplasia and brainstem thinning
mtDNA deletion
MRI: CC dysgenesis; cerebellar hypoplasia; brainstem hypoplasia
MG
Neonatal onset lactic acidosis/fetal disruption syndrome
Complex I and IV def.
? Microcephaly; MRI: ependimal cysts; cortical heterotopia; polymicrogyria; agenesis CC
MRI; biochemistry
Mitochondrial elongation factor EFTu
EFTu 602389 EFTu MRI: cystic lesions, affecting basal ganglia
MG
Female. PDH deficiency, epilepsy refractory to AED treatement
mtDNA deletion, 2 yar old female
Biancheri et al., J Inherit Metab Dis. 2011
Neonatal onset lactis acidosis/fetal disruption syndrome
Leukodystrophies Leukodystrophy Abbreviation MIM # Gene Hints from clinical
findings/ studies Diagnostic tests
Leukoencephalopathy with Brain stem and Spinal cord Involvement and elevated Lactate
LBSL 611105 DARS2 MRI: pattern characteristic, (MRS): lactate elevated
MG
Progressive cavitating leukoencephalopathy
PCL NDUFS1 COX6B1 A8344G mtDNA C6ORF66 NDUFV1
MRI: cystic lesions, affecting corpus callosum
MG
Succinate dehydrogenase def.
SDH 612848 SDHAF1
MRI: vacuolating leukodystrophy
MG
Complex 1 defect riboflavin responsive
NDUFS1 NDUFV1
MRI: vacuolating leukodystrophy
MG
Leigh Syndrome with prominent leukodystrophy
MIT 185620 SURF1 MRI: vacuolating leukodystrophy
MG
Mitochondrial elongation factor EFTu
EFTu
602389 EFTu MRI: cystic lesions, affecting basal ganglia
MG
Gene Inheritance Protein function Biochemical defects
NDUFV1, NDUFS1 AR Subunits of complex I Complex I
NUBPL AR Incorporating the Fe/S clusters
into complex I Complex I
SDHAF1 AR Complex II assembly factor Complex II
SURF1 AR understood, probably to stabilize subcomplexes during complex IV
assembly Complex IV
COX6B1 AR Subunits of complex IV Complex IV
EF-Tu AR Mitochondrial elongation factor Multiple MRC
EGF1 AR Mitochondrial elongation factor Multiple MRC
PDHA1 X-linked α subunit of the first catalytic
enzyme of the PDHC PDHC
DARS2 AR Aspartyl-tRNA synthetase Biochemical
inconsistency
EARS2 AR Glutamate-tRNA synthetase Multiple MRC
TYMP-MNGIE AR thymidine phosphorylase Multiple MRC and multiple deletions
Mitochondrial disorders presenting as Leukoencephalopathy
Suc Lac
Van der Knapp et al. Annals of Neurol. 2003; 53:252-258
Leukoencephalopathy with Brain stem and Spinal cord Involvement and elevated Lactate
PCL: Pt 2 SC Female Sib/Pt1
Ages 3, 5&7 yrs
PCL: Pt 2 SC Female Sib/Pt1
Ages 3, 5&7 yrs
1991
1994
1996
CSF
CENTRUM SEMIOVALE
CYST
CENTRUM SEMIOVALE
GRAY MATTER
P55296.3.15.15.001
PPM 4.0 3.0 2.0 1.0
P55296.3.13.16.001
PPM 4.0 3.0 2.0 1.0
P55296.3.15.21.001
PPM 4.0 3.0 2.0 1.0
P55296.3.18.9.001
PPM 4.0 3.0 2.0 1.0
P55296.3.19.16.001
PPM 4.0 3.0 2.0 1.0
Cho Cr NAA
Lac
Lac
Lac
PCL:Pt 4, MD, F, 33 m
Pt 9
A B
C
Pt. 7
Pt. 10
Ferreira et al., Neurogenetics, 2011
NDUFS1 (p.Thr595Ala)
C6ORF66-NDUFAF4, fatal panencephalopathy, consanguinty, neonatal lactic acidosis
Saada et al., The American Journal of Human Genetics, 2009 84: 718–727
EARS
Poliodystrophies Disease Abbreviati
on MIM # Gene Hints from clinical
findings or routine studies
Diagnostic tests
Alpers syndrome MTDPS4A 271245 POLG1 MRI pattern , (MRS): lactate elevated
MG
Alpers syndrome Combined oxidative phosphorylation deficiency 14
#614946 FARS2 MRI pattern MG
PDH deficiency PDH 300502 E1α MRI: cortical atrophy; (MRS): lactate elevated
MG
Mitochondrial aspartate–glutamate carrier isoform 1
AGC1 612949 AGC1 MRI: cortical atrophy MG
Mitochondrial Hsp60 Chaperon
HSP60 612233 MRI: cortical atrophy and hypomyelination
MG
Mitochondrial elongation factor G1
GFM1 606639 GFM1 MRI: cortical atrophy MG
X-linked Mitochondrial Encephalomyopathy/ Cowchock syndrome
Combined oxidative phosphorylation deficiency 6
*300169 AIFM1
MRI: cortical atrophy Neurogenic atrophy
MG; COX defect
7 year old girl, Alpers syndrome, POLG heterozygous mutation
2 year old girl, PDH defect
Hsp60 chaperonopathy Magen et al., Am J Hum Genet 83, 30–42, July 2008
AGC1 Deficiency Wibom et al., N Engl J Med 2009;361:489-95.
Pan-encephalopathies Abbreviation MIM # Gene Hints from clinical
findings or routine studies
Diagnostic tests
Severe neonatal panenecephalopathy with intractable seizures
PCH6 611523 RARS2 MRI: pattern characteristic, (MRS): lactate elevated
MG
Mutant deoxynucleotide carrier Amish microcephaly
MCPHA 607196 MCPHA MRI: simplified gyral patter, PCH high concentrations of urinary α-ketoglutarate
MG
Progressive cerebellocerebral atrophy
PCCA 613811 SepSecS MRI: cortical atrophy and cerebella r atrophy
MG
PCCA/SepSecs Agamy et al., Am J Hum Gene87, 538–544, October 8, 2010
Siu et al., Am J Med Genet Part A 152A:1747–175, 2010.
Amish Microcephaly
Kelley et al., Am J Med Genet Part A 112:318–326, 2002.
Hepatocerebral syndromes #203700 Mitochondrial DNA depletion syndrome 4 (ALPERS) POLG #256810 Mitochondrial DNA depletion syndrome 6 MPV17 *606075 Mitochondrial DNA Depletion Syndrome 7 TWINKLE C10ORF2 #614946 Combined oxidative phosphorylation deficiency 14 FARS2 (PheRS) Leigh syndrome #220111 Leigh syndrome, French-Canadian type; LSFC (COX defect) LRPPRC Myopathic type and Leigh syndrome type with hepathopathy #614739 MEGDEL or MEGDHEL SERAC1 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome Liver failure #251880 Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) DGUOK Transient Liver failure *610230 Liver failure, transient infantile TRMU *191330 Mitochondrial complex III deficiency, nuclear type 3 UQCRB
Mitochondrial Hepatopathies Clinical, and biochemical classification
Other syndromes #124000 Mitochondrial complex III deficiency, nuclear type 1 BCS1L • Encephalopathy, and delayed psychomotor development. Visceral involvement, including hepatopathy and renal tubulopathy. • GRACILE (growth retardation, amino aciduria, cholestasis, iron overload, lactic acidosis, and early death) • Bjornstad syndrome sensorineural hearing loss and pili torti. #611126 ACAD9 deficiency acyl-CoA dehydrogenase-9 acute metabolic acidosis, hypertrophic cardiomyopathy, and muscle weakness associated with a deficiency of mitochondrial complex I activity in muscle, liver, Liver failure – HCM #615595 Combined oxidative phosphorylation deficiency 19 LYRM4 One family Lebanese and Syrian ancestry : respiratory distress, hypotonia, and severe lactic acidosis in the newborn period; slow improvement #609060 Combined oxidative phosphorylation deficiency 1 GFM1 mitochondrial elongation factor G1 Early fatal progressive hepatoencephalopathy
Laboratory of Molecular Medicine Rosalba Carrozzo, PhD Fiorella Piemonte, PhD Giulia Tozzi, PhD Alessandra Torraco, PhD Maria Chiara Meschini, PhD Marzia Bianchi. PhD Teresa Rizza, PhD Daniela Verrigni, PhD
Unit of Metabolic Disease Carlo Dionisi Vici, MD Diego Martinelli, MD